Tag: Pfizer Oral Pill For Covid

Pfizer has said that Paxlovid reduces the risk of hospitalisation or death in Covid-19 patients by 89 per cent.

New York: US pharmaceutical company Pfizer has begun Phase 1 clinical trial of a novel oral antiviral drug for SARS-CoV-2, the virus that causes Covid-19. The oral antiviral clinical candidate “PF-07321332”, a SARS-CoV2-3CL protease inhibitor, has demonstrated potent in vitro anti-viral activity against SARS-CoV-2, as well as activity against other coronaviruses, the company said in […]